Novel BCL2 inhibitor, Disarib induces apoptosis by disruption of BCL2-BAK interaction.
Vartak SV, Iyer D, Santhoshkumar TR, Sharma S, Mishra A, Goldsmith G, Srivastava M, Srivastava S, Karki SS, Surolia A, Choudhary B, Raghavan SC.
Vartak SV, et al. Among authors: choudhary b.
Biochem Pharmacol. 2017 May 1;131:16-28. doi: 10.1016/j.bcp.2017.02.015. Epub 2017 Feb 20.
Biochem Pharmacol. 2017.
PMID: 28223017